Grand Pharmaceutical Group Ltd 2025 Sustainability Report
Company: Grand Pharmaceutical Group Ltd
Sector: Manufacturing
Country: Hong Kong
Year: 2025
Type: Sustainability Report
Pages: 72
The report presents a 2025 ESG program built around double materiality, TCFD/IFRS S2-aligned climate governance and a full Scope 1-3 inventory totaling 1,188,103.57 tonnes of CO2 equivalent. It set a 10% reduction target for GHG emission intensity by 2030 from a 2023 base year. The workforce disclosure reports 12,614 employees, while the report states that no work-related injuries or fatalities occurred during the period.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.